C.I. MedicalLtd (TSE:3540) - Stock Price, News & Analysis

3540 Stock Overview

Designs, manufactures, and sells dental care products in Japan.

3540 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	2/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings are forecast to grow 23.37% per year

Risk Analysis

Debt is not well covered by operating cash flow

C.I. Medical Co.,Ltd. Competitors

Vital KSK Holdings

TSE:3151

JP¥55.5b

TOKAI

TSE:9729

JP¥65.0b

WIN-Partners

TSE:3183

JP¥31.5b

Nippon Care Supply

TSE:2393

JP¥30.8b

Price History & Performance

Summary of all time highs, changes and price drops for C.I. MedicalLtd
Historical stock prices
Current Share Price	JP¥878.00
52 Week High	JP¥1,080.00
52 Week Low	JP¥669.00
Beta	0.77
11 Month Change	-2.77%
3 Month Change	9.89%
1 Year Change	-6.30%
33 Year Change	-33.99%
5 Year Change	76.38%
Change since IPO	82.92%

Recent updates

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20

The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On

Jul 07

Shareholder Returns

	3540	JP Healthcare	JP Market
7D	-11.3%	-8.7%	-11.1%
1Y	-6.3%	-2.3%	4.7%

Return vs Industry: 3540 underperformed the JP Healthcare industry which returned -2.3% over the past year.

Return vs Market: 3540 underperformed the JP Market which returned 4.7% over the past year.

Price Volatility

Is 3540's price volatile compared to industry and market?
3540 volatility
3540 Average Weekly Movement	6.1%
Healthcare Industry Average Movement	5.8%
Market Average Movement	6.1%
10% most volatile stocks in JP Market	9.7%
10% least volatile stocks in JP Market	3.2%

Stable Share Price: 3540 has not had significant price volatility in the past 3 months.

Volatility Over Time: 3540's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2000	473	Kiyoto Shimizu	www.ci-medical.co.jp

C.I. Medical Co.,Ltd. designs, manufactures, and sells dental care products in Japan. The company offers tooth brushes; and other dental care products through mail order sales.

C.I. Medical Co.,Ltd. Fundamentals Summary

How do C.I. MedicalLtd's earnings and revenue compare to its market cap?
3540 fundamental statistics
Market cap	JP¥44.70b
Earnings (TTM)	JP¥1.81b
Revenue (TTM)	JP¥46.58b

24.3x

P/E Ratio

0.9x

P/S Ratio

Is 3540 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3540 income statement (TTM)
Revenue	JP¥46.58b
Cost of Revenue	JP¥34.40b
Gross Profit	JP¥12.17b
Other Expenses	JP¥10.37b
Earnings	JP¥1.81b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 13, 2024

Earnings per share (EPS)	36.16
Gross Margin	26.14%
Net Profit Margin	3.88%
Debt/Equity Ratio	85.3%

How did 3540 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

14%

Payout Ratio

3540 Stock Overview

Rewards

Risk Analysis

C.I. Medical Co.,Ltd. Competitors

TSE:3151

JP¥55.5b

TSE:9729

JP¥65.0b

TSE:3183

JP¥31.5b

TSE:2393

JP¥30.8b

Price History & Performance

Recent News & Updates

New minor risk - Share price stability

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 20%

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

Recent updates

New minor risk - Share price stability

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 20%

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: JP¥51.29 (vs JP¥57.01 in 3Q 2022)

C.I. Medical Co.,Ltd. to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥70.50 (vs JP¥65.91 in 2Q 2022)

C.I. Medical Co.,Ltd. to Report Q2, 2023 Results on Aug 08, 2023

First quarter 2023 earnings released: EPS: JP¥52.10 (vs JP¥86.91 in 1Q 2022)

Full year 2022 earnings: EPS misses analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 16%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

C.I. Medical Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥28.50 per share

Third quarter 2022 earnings released: EPS: JP¥57.01 (vs JP¥65.91 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥56.99 (vs JP¥65.91 in 3Q 2021)

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Naiki Shiken Ltd. from Yuichi Naiki and Yuriko Naiki.

C.I. Medical Co.,Ltd. to Report Q3, 2022 Results on Nov 08, 2022

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Sakura Dental Laboratory from Akira Ochi and Katsumi Ochi.

Second quarter 2022 earnings released: EPS: JP¥65.90 (vs JP¥67.61 in 2Q 2021)

C.I. Medical Co.,Ltd. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to JP¥4,300

C.I. Medical Co.,Ltd. to Report Q1, 2022 Results on May 10, 2022

Investor sentiment improved over the past week

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 24, 2022

Full year 2021 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased to JP¥5,300

Third quarter 2021 earnings released: EPS JP¥65.89 (vs JP¥81.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥67.61 (vs JP¥65.10 in 2Q 2020)

Investor sentiment deteriorated over the past week

Looop Inc. agreed to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. and Yotsuba Electric Power Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥87.40 (vs JP¥48.50 in 1Q 2020)

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Investor sentiment improved over the past week

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

New 90-day low: JP¥5,490

Analysts increase EPS estimates to JP¥320

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

C.I. Medical Co.,Ltd. (JASDAQ:3540) acquired 22.4% stake in Fuji Dental Lab Co., Ltd.

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Revenue and earnings beat expectations

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?